// App-Quantinova.ai

: COMPARISON OF JNJ9375, A THROMBIN EXOSITE 1-DIRECTED ANTIBODY, WITH APIXABAN FOR THROMBOPROPHYLAXIS AFTER ELECTIVE KNEE REPLACEMENT SURGERY: TEXT-TKR STUDY

Researchers

Presenter

  • Jeffrey I. Weitz

Principal Investigators

  • Gary Raskob

  • Michael Rud Lassen

  • Annelise Segers

  • Charles Francis

  • Robin Roberts

  • Takeshi Fuji

  • Gary Peters

  • Renee Swaim

  • Maureen Johnson

  • Juliane Bernholz

  • Michael Lee

  • John Strony

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Evithrom

Outcome

  • N/A

Study Design

  • Randomized

  • Adaptive

  • Double Blind/Blinded

  • Parallel Group

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved